Video

Meet Our Guests: EVQLV's Andrew Satz And Recursion's Tina Larson

Source: Cytiva

Computational biology and the big data, artificial intelligence, and machine learning tools that drive it have become firmly ensconced in drug discovery and early development. Bioprocess Online Live tapped two leading experts to headline the digital event, How Computational Biology Speeds Drug Discovery, Development. Meet our guests, EVQLV CEO and Co-Founder Andrew Satz and Recursion President & COO Tina Larson, and learn about their inspiration for bringing a Silicon Valley mentality to biotech.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva